Information Provided By: 
Fly News Breaks for October 12, 2018
ILMN
Oct 12, 2018 | 07:19 EDT
Deutsche Bank analyst Dan Leonard raised his price target for Illumina to $350 saying he sees bias to the upside for estimates over the next 6-12 months. Further, enough positive newsflow in the clinical markets should keep investors enthused about the total addressable market for nextgen sequencing, Leonard tells investors in a research note. He sees "lots of green arrows" and keeps a Buy rating on Illumina.
News For ILMN From the Last 2 Days
There are no results for your query ILMN
